AngioSoma to Advertise in U.S. Airports
22 avr. 2019 09h30 HE
|
AngioSoma, Inc.
HOUSTON, TX, April 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma, Inc. (OTC: SOAN), a leading developer of dietary supplements, is pleased to announce a one-year advertising contract...
AngioSoma Launches E-Commerce Website
15 avr. 2019 09h30 HE
|
AngioSoma, Inc.
HOUSTON, TX, April 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma, Inc. (OTC: SOAN), a leading developer of dietary supplements and biotechnology research and development company, is...
AngioSoma Announces Acquisition of Diabetes Relief
14 déc. 2018 10h57 HE
|
AngioSoma, Inc.
Houston, TX, Dec. 14, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma, Inc. (OTC: SOAN) announced today the Company has entered into a partially binding letter of intent to acquire 100% of...
AngioSoma Launching Holiday Awareness Campaign
12 nov. 2018 07h00 HE
|
AngioSoma, Inc.
Heart Health Focused Campaign Set to Kick Off December 1st, 2018 HOUSTON, TX, Nov. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – AngioSoma (OTC: SOAN), a leading biotechnology research and...
AngioSoma Committed to Expanding Cosmeceutical Future
08 nov. 2018 09h50 HE
|
AngioSoma, Inc.
New Industry Data and Product Roadmap Align for Optimistic Outlook HOUSTON, Nov. 08, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma (OTC: SOAN), a leading biotechnology research and...
StemStrength Deluxe Now Available on Amazon.com
22 oct. 2018 06h00 HE
|
AngioSoma, Inc.
SomaCeuticals, an AngioSoma Inc. Subsidiary, Leverages Online Retail Giant for New Deluxe Formula of its Flagship Product HOUSTON, TX, Oct. 22, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE –...
AngioSoma, Inc. Announces Selection of Regulatory Firm for Flagship Drug
18 juin 2018 11h44 HE
|
AngioSoma, Inc.
HOUSTON, TX, June 18, 2018 (GLOBE NEWSWIRE) -- AngioSoma, Inc. (SOAN) is excited to announce that we have identified a regulatory firm who can assist taking our patented flagship drug, Liprostin™,...
AngioSoma, Inc. Announces Grant of Patent for Flagship Drug
14 mai 2018 12h13 HE
|
AngioSoma, Inc.
HOUSTON, TX, May 14, 2018 (GLOBE NEWSWIRE) -- AngioSoma, Inc. (OTC: SOAN) is excited to announce that the U.S. Patent Office has agreed to grant our patent application for our flagship...